Mesothelioma News

Navy Vet’s Family Pursues Justice Following Mesothelioma Death

Published on October 03, 2022

Nearly 70 years after serving in the U.S. Navy, Keith W. Hipwell died of malignant mesothelioma, the rare and deadly…

T Cell Biotech Test Successfully Shrinks Mesothelioma Tumors

Published on September 30, 2022

The last few weeks have seen a flurry of exciting news regarding innovative mesothelioma treatments, including news yesterday that biotech…

Orphan Drug Status Granted to Promising Mesothelioma Drug

Published on September 29, 2022

Days after being approved for its first-in-human trials, Verismo’s SynKIR-110 immunotherapy drug has been granted orphan drug designation for the…

Report Confirms that Medical Debt Adds to Mesothelioma Patients’ Woes

Published on September 28, 2022

When you’ve been diagnosed with malignant mesothelioma, the cost of medical care should be the least of your worries. Unfortunately,…

Report Confirms What’s Long Been Known: Asbestos Bans Work to Prevent Mesothelioma

Published on September 27, 2022

A study conducted by Spanish epidemiologists and occupational health experts has reached a conclusion long assumed by mesothelioma victims: the…

Drug Company Identifies Protein that Makes Mesothelioma More Susceptible to Treatment

Published on September 26, 2022

Though chemotherapy is effective against many forms of cancer, the deadly asbestos-related form of the disease known as malignant mesothelioma…

Woman’s Asbestos-related Lung Cancer Blamed on Second-Hand Exposure

Published on September 23, 2022

A lawsuit making its way through the Louisiana court system is profiling how mesothelioma and other deadly diseases can afflict…

Dutch Study Identifies Indicator of Keytruda Effectiveness for Mesothelioma

Published on September 22, 2022

Immunotherapy treatments like Keytruda (pembrolizumab) offer significant hope for mesothelioma patients. The innovative medication has been shown to significantly extend…

Mesothelioma Study Yields Disappointing Conclusion about Adjuvant Radiation

Published on September 21, 2022

The treatment options offered to mesothelioma patients largely depend upon the stage of their disease and their specific condition, but…

Immunotherapy Treatment for Mesothelioma Receives FDA Clearance for Human Testing

Published on September 20, 2022

The U.S. Food and Drug Administration has cleared a first-in-human Phase 1 clinical trial of an immunotherapy drug that will…